Sahajanand Medical Technologies IPO allotment today; GMP at 7%, check status on BSE, NSE and registrar

Qualified institutional buyers (QIBs) led the demand, subscribing to their allotted portion 34.70 times. The non-institutional investor (NII) category was subscribed 14.64 times, while the retail investor portion received bids for 3.03 times the shares reserved for the category. Read Also: 'From 2 crore investors to over 13 crore in 10 years': Zerodha's Nithin Kamath credits Jio for India's retail investing boom

In the grey market, Sahajanand Medical Technologies shares were commanding a premium of nearly 7 percent on October 21, according to InvestorGain. Grey market premium (GMP) is an unofficial indicator of investor sentiment and does not guarantee listing gains. The company's shares are scheduled to list on the BSE and NSE on October 23. Sahajanand Medical Technologies IPO allotment status: How to check

Investors can check their allotment status online through the registrar's website or the stock exchanges once the results are made available. Check allotment status on the registrar's website Step 1. Visit the MUFG Intime public issues portal at https://in.mpms.mufg.com/Initial_Offer/public-issues.html Step 2. Navigate to the IPO allotment status section. Step 3. Select Sahajanand Medical Technologies from the issue list, if available.

Step 4. Enter the required details, such as PAN or application number, and submit. Step 5. Your allotment status will be displayed once the results are published. Check allotment status on BSE 1. Visit the BSE IPO application status page at https://www.bseindia.com/investors/appli_check 2. Select 'Equity' as the issue type. 3. Choose Sahajanand Medical Technologies from the IPO list. 4. Enter your application number or PAN, as requested.

5. Submit the details to view the status. Check IPO bid details on NSE Step 1. Go to the NSE IPO bid verification page at https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids Step 2. Follow the instructions to verify your IPO bid details. Step 3. Enter the information requested on the page. Step 4. Your allotment status will be displayed once the results are published. The IPO was open for subscription from October 15 to October 19.

The company is raising Rs 475.48 crore entirely through an offer for sale (OFS) of approximately 1.38 crore equity shares. Since the issue is entirely an OFS, the proceeds from the sale will go to the selling shareholders, and Sahajanand Medical Technologies will not receive the money raised through the offering. The price band was fixed at Rs 327 to Rs 344 per share. The minimum application consisted of 43 shares, requiring an investment of Rs 14,792 at the upper end of the price band.

Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities and Capital Markets (India), and Nuvama Wealth Management are the merchant bankers to the issue. Ahead of the public issue, Sahajanand Medical Technologies raised Rs 140.06 crore from anchor investors. The company allotted approximately 40.71 lakh equity shares to eight institutional investors on October 14 at the upper end of the price band.

Five domestic mutual fund houses, Nippon Life India, DSP Mutual Fund, WhiteOak Capital, Invesco India and UTI AMC, received around 30.25 lakh shares worth approximately Rs 104 crore through seven schemes. Other participants in the anchor book included Allianz Global Investors Fund, Tata AIA Life Insurance Company and Natixis International Funds. About Sahajanand Medical Technologies Mumbai-headquartered Sahajanand Medical Technologies develops medical devices used in cardiovascular and vascular interventions.

Its portfolio includes coronary stents and coronary balloons, as well as structural heart products such as transcatheter aortic valve implantation (TAVI) devices and occluders. The company also offers renal stents under its own brand and peripheral drug-coated balloons (DCBs). Its products are used in procedures aimed at treating cardiovascular conditions and other vascular disorders.